CD4 and neoplasm: Tumour-infiltrating CD4+ T cells recognize antigens presented through MHC II, by conventional antigen-presenting cells (dendritic cells, B lymphocytes and macrophages), able to capture, process and present tumour antigens derived by cancer cells.